Incepta Vaccine Ambitions Bridled By Bangladesh Regulatory Gap
This article was originally published in Scrip
Executive Summary
Bangladesh's Incepta Vaccine Ltd is gearing for a larger play with vaccines for pneumonia and human papillomavirus (HPV) in the pipeline, but a non-functional national regulatory authority (NRA) could stymie its ambitions in terms of large scale supplies of other products to Unicef, at least in the short-term.